Literature DB >> 12604270

Low-dose tacrolimus for intractable myasthenia gravis.

Hiroaki Yoshikawa1, Kazunori Mabuchi, Yoshihiro Yasukawa, Masaharu Takamori, Masahito Yamada.   

Abstract

We treated two patients suffering from intractable myasthenia gravis (MG) with low-dose tacrolimus plus prednisolone. Both patients showed significant improvement of myasthenic signs, accompanied by suppressed serum anti-acetylcholine receptor antibody, waning in compound muscle action potential by repetitive nerve stimulation and IL-2 production by peripheral blood mononuclear cells. Low-dose tacrolimus plus prednisolone is a promising therapeutic regimen for intractable MG. Copyright 2002 Elsevier Science Ltd.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12604270     DOI： 10.1054/jocn.2001.0907

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN： 0967-5868            Impact factor:   1.961


  6 in total

1.  Efficacy of tacrolimus in treatment of polymyositis associated with myasthenia gravis.

Authors:  Yasuhiro Shimojima; Takahisa Gono; Kanji Yamamoto; Kenichi Hoshi; Masayuki Matsuda; Kunihiro Yoshida; Shu-ichi Ikeda
Journal:  Clin Rheumatol       Date:  2004-03-24       Impact factor: 2.980

Review 2.  Efficacy and safety of tacrolimus for myasthenia gravis: a systematic review and meta-analysis.

Authors:  Liang Wang; Suxian Zhang; Jianying Xi; Wenhui Li; Lei Zhou; Jun Lu; Jiahong Lu; Tiansong Zhang; Chongbo Zhao
Journal:  J Neurol       Date:  2017-09-18       Impact factor: 4.849

Review 3.  Update on myasthenia gravis.

Authors:  B R Thanvi; T C N Lo
Journal:  Postgrad Med J       Date:  2004-12       Impact factor: 2.401

4.  Autoimmune Myasthenia Gravis: Recommendations for Treatment and Immunologic Modulation.

Authors:  Vern C Juel; Janice M Massey
Journal:  Curr Treat Options Neurol       Date:  2005-01       Impact factor: 3.972

5.  Toxicities of immunosuppressive treatment of autoimmune neurologic diseases.

Authors:  Enrico C Lallana; Camilo E Fadul
Journal:  Curr Neuropharmacol       Date:  2011-09       Impact factor: 7.363

6.  Clinical Evaluation of the Efficacy and Safety of Co-Administration of Wuzhi Capsule and Tacrolimus in Adult Chinese Patients with Myasthenia Gravis.

Authors:  Yuyao Peng; Fei Jiang; Ran Zhou; Wanlin Jin; Yi Li; Weiwei Duan; Liqun Xu; Huan Yang
Journal:  Neuropsychiatr Dis Treat       Date:  2021-07-12       Impact factor: 2.570
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.